Banner Pharmacy Recalls Magnesium Sulfate IV Bags Due to Sterility Concerns
Banner Pharmacy Services is recalling 7,578 bags of Magnesium sulfate 10 Gm in Lactated Ringer's due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric for drug recalls involving potential adverse health consequences.
Plain-English summary
Banner Pharmacy Services, LLC is recalling 7,578 bags of Magnesium sulfate 10 Gm added to Lactated Ringer's 250 mL bags. The product is prescription-only and was distributed nationwide within the United States. The recall involves multiple lots with expiration dates ranging from October 20, 2017, to February 23, 2018.
The recall was initiated due to a lack of assurance of sterility. This classification indicates a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should discontinue use of the affected lots and contact Banner Pharmacy Services for further instructions or replacement.
The recalled product
- Product
- Magnesium sulfate 10 Gm added to Lactated Ringer's 250 mL bags, Rx Only, Banner Health Compounding Pharmacy 7300 W Detroit St Chandler, AZ 95226, NDC 7025003201
- Manufacturer
- Banner Pharmacy Services, LLC
- Category
- Drug — IV Compounded Medication
- Hazard
- Affected units
- 7,578
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 042017S4
- Exp 10/20/2017
- 042517S2
- 10/25/2017
- 042617S3
- Exp 10/26/2017
- 050317S2
- Exp 11/2/2017
- 050517S3
- Exp 11/4/2017
- 051217S2
- Exp 11/11/2017
- 051917S1
- Exp 11/18/2017
- 052917S4
- Exp 11/28/2017
- 061317S5
- Exp 12/13/2017
- 061617S1
- Exp 12/16/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Banner Pharmacy Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Banner Pharmacy Services, LLC
See all →- SevereBanner Pharmacy Recalls Fentanyl Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Oxytocin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Health Recalls Vancomycin Bags Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
- SevereBanner Pharmacy Recalls Ropivacaine HCL Cassettes Due to Sterility Concerns
FDA (Drugs) · 2017-11-01
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SeverePharmakon Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- SevereZions RX Formulations Recalls Magnesium Sulfate Bags Due to Sterility Concerns
FDA (Drugs) · 2014-04-16
- SevereMagnesium Sulfate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereDowning Labs Recalls Magnesium Sulfate Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereGuardian Pharmacy Recalls Magnesium Sulfate Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereSCA Pharmaceuticals Recalls Magnesium Sulfate Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-02